FDA Inspection 1207405 — Terumo BCT Ltd
The FDA completed an inspection of Terumo BCT Ltd on February 11, 2022 in Larne. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 11, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Larne (United Kingdom)
Additional Details
Mutual Recognition Agreement (MRA)